<<+others>> for the HIV Modelling Consortium
Introduction
The following questions are put together to solicit opinion from expert virologists. Please indicate your answers quantitatively and provide comments which may give rational for your answers. The aim is to determine areas of agreement and uncertainty and to assist the parametrisation of mathematical models.
Definitions
The focus here is specifically on PrEP being a daily oral dose of TDF or TDF/FTC, and ART being TDF-based. Please indicate if you use data that do not correspond to these definitions. 
Instructions

For each question there is a line with a scale and we ask for an indication of where on that line the true value lies (location and uncertainty
